
CHMP Recommends EU Approval of AQNEURSA® for Niemann-Pick Type C
IntraBio’s AQNEURSA® Gains CHMP Recommendation for Niemann-Pick Disease Type C, Signaling Major Breakthrough in Rare Neurological Disorder Treatment In a landmark development for the rare disease community, IntraBio Inc., a pioneering biopharmaceutical company specializing in therapies for rare and debilitating…